NAALADASE INHIBITORS FOR TREATING HUNTINGTON'S DISEASE

Title:

NAALADASE INHIBITORS FOR TREATING HUNTINGTON'S DISEASE

Document Type and Number:

WIPO Patent Application WO2003057154

Kind Code:

A3

Abstract:

This invention relates to a pharmaceutical composition and a method for treating Huntington's disease using NAALADase inhibitors.

More Like This:

JP2000212092	ANTIVIRUS AND ANTIBACTERIAL AGENT
WO/2014/173510	HIGHLY CONCENTRATED FORMULATIONS OF SOLUBLE Fc RECEPTORS
JP2002540143	[Title of Invention] New Use of GABAB Receptor Ligand

Inventors:

SLUSHER BARBARA S (US)
WOZNIAK KRYSTYNA (US)

Application Number:

PCT/US2002/041571

Publication Date:

January 29, 2004

Filing Date:

December 27, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GUILDFORD PHARMACEUTICALS INC (US)
SLUSHER BARBARA S (US)
WOZNIAK KRYSTYNA (US)

International Classes:

A61K31/00; A61K31/185; A61K31/194; A61K31/195; A61K31/255; A61K31/341; A61K31/415; A61K31/575; A61K31/662; (IPC1-7): A61K31/65

Foreign References:

US5985855A

1999-11-16

Download PDF:

View/Download PDF PDF Help

Previous Patent: AQUEOUS BASED PHARMACEUTICAL FORMULATIONS OF WATER-SOLUBLE PRODRUGS OF PROPOFOL

Next Patent: MONOCLONAL ANTIBODY IMAGING AND THERAPY OF TUMORS THAT EXPRESS MET AND BIND HEPATOCYTE GROWTH FACTOR